Coronavirus and hypertension: is there a link between the medication and complication of coronavirus?

Despite the concerns expressed by some experts, common medications for hypertension did not increase the risk of infection COVID-19 – or the development of serious disease – in the study took участие12 594 patients.

A study published may 1 in the Medical journal New England, began in response to a joint statement issued on 17 March, the American heart Association, American College of cardiology and American society of heart failure. Experts urgently called for a study to answer the question posed in previous studies: worsen are drugs to treat hypertension (antihypertensives and medications pressure) results of treatment of coronavirus COVID-19? It should be emphasized that these drugs are often used by patients around the world.

Conducted by scientists from Medical school at new York University. Grossman, the study found no connection between the treatment of four classes of drugs – inhibitors of angiotensin converting enzyme (ACE), the angiotensin receptor blockers (ARBS), beta blockers or calcium channel blockers and an increased probability of a positive test for COVID-19.

Find out the first symptoms of coronavirus human. How to identify an asymptomatic patient?

In addition, the study showed a significant increase in the risk of a more severe course of the disease (intensive therapy, the use of mechanical ventilation or death) in any treatment of patients with the pandemic virus.

Antihypertensive drugs pressure is safe to take even with the coronavirus

“Since almost half of the U. S. adult population has high blood pressure, and patients with cardiovascular disease are more susceptible to COVID-19, understanding the relationship between these commonly used drugs and COVID-19 was a serious problem for health”, – said the chief researcher of the harmony Reynolds, associate Director, cardiovascular Center for clinical research at NYU Langone Health. “Our results should convince the medical community and patients that they continue to use these commonly prescribed drugs, which in themselves prevent potentially serious cardiac events.”

See the statistics of coronavirus by regions

For the purposes of the study, the researchers identified patients in the electronic medical record Langone Health at new York University with the test results COVID-19. For each patient identified with the test results COVID-19, the team carefully insulated medical history necessary for the analysis, comparing treated and untreated patients.

“Before our study there were no experimental or clinical data showing the effects of using these drugs in one way or another in the presence of the risk of developing COVID-19,” says senior study author Judith Hohmann, MD, Professor of family medicine Harold Snyder and senior Vice Dean for science at NYU Langone Clinic Health. “In terms of next steps, our plan is to use similar approaches to study other drugs and their Association with disease COVID-19 and the coronavirus”.